Discussion: Breast Implant–Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased Risk
Author:
- 1 October 2017
- journal article
- editorial
- Published by Wolters Kluwer Health in Plastic and Reconstructive Surgery
- Vol. 140 (4) , 660-662
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Breast Implant–Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand: High-Surface-Area Textured Implants Are Associated with Increased RiskPlastic and Reconstructive Surgery, 2017
- U.S. Epidemiology of Breast Implant–Associated Anaplastic Large Cell LymphomaPlastic and Reconstructive Surgery, 2017
- Global Adverse Event Reports of Breast Implant–Associated ALCL: An International Review of 40 Government Authority DatabasesPlastic and Reconstructive Surgery, 2017
- CD30+ T Cells in Late Seroma May Not Be Diagnostic of Breast Implant-Associated Anaplastic Large Cell LymphomaAesthetic Surgery Journal, 2017
- NCCN Consensus Guidelines for the Diagnosis and Management of Breast Implant-Associated Anaplastic Large Cell LymphomaAesthetic Surgery Journal, 2017
- Risk Factor Analysis for Capsular Contracture, Malposition, and Late Seroma in Subjects Receiving Natrelle 410 Form-Stable Silicone Breast ImplantsPlastic and Reconstructive Surgery, 2017
- Racial Patterns of Peripheral T-Cell Lymphoma Incidence and Survival in the United StatesJournal of Clinical Oncology, 2016
- Complete Surgical Excision Is Essential for the Management of Patients With Breast Implant–Associated Anaplastic Large-Cell LymphomaJournal of Clinical Oncology, 2016
- Characteristics and Treatment of Patients with Breast Implant-Associated Anaplastic Large Cell Lymphoma Presenting with Aggressive FeaturesPlastic and Reconstructive Surgery, 2015
- Anaplastic Large Cell Lymphoma Occurring in Women with Breast ImplantsPlastic and Reconstructive Surgery, 2015